These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 22261894)

  • 1. AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model.
    Raake PW; Schlegel P; Ksienzyk J; Reinkober J; Barthelmes J; Schinkel S; Pleger S; Mier W; Haberkorn U; Koch WJ; Katus HA; Most P; Müller OJ
    Eur Heart J; 2013 May; 34(19):1437-47. PubMed ID: 22261894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure.
    Rengo G; Lymperopoulos A; Zincarelli C; Donniacuo M; Soltys S; Rabinowitz JE; Koch WJ
    Circulation; 2009 Jan; 119(1):89-98. PubMed ID: 19103992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of βARKct engineered cellular extracellular vesicles and model specific cardioprotection.
    Kwon JS; Schumacher SM; Gao E; Chuprun JK; Ibetti J; Roy R; Khan M; Kishore R; Koch WJ
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1276-H1289. PubMed ID: 33513081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GRK2 as a novel gene therapy target in heart failure.
    Rengo G; Lymperopoulos A; Leosco D; Koch WJ
    J Mol Cell Cardiol; 2011 May; 50(5):785-92. PubMed ID: 20800067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractility.
    Salazar NC; Vallejos X; Siryk A; Rengo G; Cannavo A; Liccardo D; De Lucia C; Gao E; Leosco D; Koch WJ; Lymperopoulos A
    Cell Commun Signal; 2013 Aug; 11():64. PubMed ID: 23984976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCARD-mediated gene transfer of GRK2 inhibitor in ovine model of acute myocardial infarction.
    Swain JD; Fargnoli AS; Katz MG; Tomasulo CE; Sumaroka M; Richardville KC; Koch WJ; Rabinowitz JE; Bridges CR
    J Cardiovasc Transl Res; 2013 Apr; 6(2):253-62. PubMed ID: 23208013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction.
    Shah AS; White DC; Emani S; Kypson AP; Lilly RE; Wilson K; Glower DD; Lefkowitz RJ; Koch WJ
    Circulation; 2001 Mar; 103(9):1311-6. PubMed ID: 11238278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute ischemic cardiac dysfunction is attenuated via gene transfer of a peptide inhibitor of the beta-adrenergic receptor kinase (betaARK1).
    Tevaearai HT; Walton GB; Keys JR; Koch WJ; Eckhart AD
    J Gene Med; 2005 Sep; 7(9):1172-7. PubMed ID: 15880449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral beta-adrenergic receptor kinase inhibitor gene transfer improves exercise capacity, cardiac contractility, and systemic inflammation in a model of pressure overload hypertrophy.
    Gupta D; Molina EJ; Palma J; Gaughan JP; Long W; Macha M
    Cardiovasc Drugs Ther; 2008 Oct; 22(5):373-81. PubMed ID: 18690529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right ventricular beneficial effects of beta adrenergic receptor kinase inhibitor (betaARKct) gene transfer in a rat model of severe pressure overload.
    Molina EJ; Gupta D; Palma J; Gaughan JP; Macha M
    Biomed Pharmacother; 2009 Jun; 63(5):331-6. PubMed ID: 18801641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral.βARKct Cardiac Gene Therapy Ameliorates Cardiac Function Following Cardiopulmonary Bypass in A Swine Model.
    Cong M; Fan Y; Zhu F; Ji X; Sun L; Yang M; Li N; Li Q; Tan Q
    Shock; 2020 Oct; 54(4):563-573. PubMed ID: 31895875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV6-βARKct gene delivery mediated by molecular cardiac surgery with recirculating delivery (MCARD) in sheep results in robust gene expression and increased adrenergic reserve.
    Katz MG; Fargnoli AS; Swain JD; Tomasulo CE; Ciccarelli M; Huang ZM; Rabinowitz JE; Bridges CR
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):720-726.e3. PubMed ID: 22143102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model.
    Pleger ST; Shan C; Ksienzyk J; Bekeredjian R; Boekstegers P; Hinkel R; Schinkel S; Leuchs B; Ludwig J; Qiu G; Weber C; Raake P; Koch WJ; Katus HA; Müller OJ; Most P
    Sci Transl Med; 2011 Jul; 3(92):92ra64. PubMed ID: 21775667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms.
    Brinks H; Boucher M; Gao E; Chuprun JK; Pesant S; Raake PW; Huang ZM; Wang X; Qiu G; Gumpert A; Harris DM; Eckhart AD; Most P; Koch WJ
    Circ Res; 2010 Oct; 107(9):1140-9. PubMed ID: 20814022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure.
    Rengo G; Leosco D; Zincarelli C; Marchese M; Corbi G; Liccardo D; Filippelli A; Ferrara N; Lisanti MP; Koch WJ; Lymperopoulos A
    Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2032-8. PubMed ID: 20304818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model.
    Weber C; Neacsu I; Krautz B; Schlegel P; Sauer S; Raake P; Ritterhoff J; Jungmann A; Remppis AB; Stangassinger M; Koch WJ; Katus HA; Müller OJ; Most P; Pleger ST
    Gene Ther; 2014 Feb; 21(2):131-8. PubMed ID: 24305416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urocortin 3 Gene Transfer Increases Function of the Failing Murine Heart.
    Giamouridis D; Gao MH; Lai NC; Tan Z; Kim YC; Guo T; Miyanohara A; Blankesteijn MW; Biessen EAL; Hammond HK
    Hum Gene Ther; 2019 Jan; 30(1):10-20. PubMed ID: 30003813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral βARKct Cardiac Gene Transfer Ameliorates Postresuscitation Myocardial Injury in a Porcine Model of Cardiac Arrest.
    Shang D; Zhu F; Tan Q; Hu B; Liu D; Cong M; Song J; Li T; Ji X
    Shock; 2019 Dec; 52(6):631-638. PubMed ID: 31725109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction.
    Schumacher SM; Gao E; Zhu W; Chen X; Chuprun JK; Feldman AM; Tesmer JJ; Koch WJ
    Sci Transl Med; 2015 Mar; 7(277):277ra31. PubMed ID: 25739765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. betaARKct: a therapeutic approach for improved adrenergic signaling and function in heart disease.
    Brinks H; Koch WJ
    J Cardiovasc Transl Res; 2010 Oct; 3(5):499-506. PubMed ID: 20623214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.